Harrow Health is trading at $41.92, up +6.40% on August 19, 2026, amid sector rotation and stronger healthcare sentiment alongside a 3.23% healthcare-sector advance.
- No new company-specific announcement dated August 19 was identified.
- Latest earnings showed $70.7 million in second-quarter revenue and reaffirmed 2026 guidance, but reported a $0.46 adjusted loss per share.